COMPANY OVERVIEW

Company Album

Basic Information
Hybribio is an innovative company in the field of life sciences, endeavoring to apply assay technologies to commercial use. With the commitment to the betterment of human healthcare, we are dedicated to technology breakthrough and product innovation. Becoming the leading provider for HPV diagnostic markets is our company goal. Having a complete operation chain from R & D, manufacturing, to sales & service, we serve the community with uncompromised service and product quality. At present, our core business operation focuses on a series of DNA analyzing instruments and diagnostic reagents for HPV (Human Papillomavirus) testing. Our manufacturing is operated under strict GMP and ISO standards, a series of international scientific publications and achievements of technology have been recognized and awarded. We are the ONLY HPV assay provider appointed by the Cervical Cancer Prevention Program in China (CPPC) and the most recognized partner by medical institutions in China. Creativity, professionalism and people oriented characteristics are in the culture of Hybribio. Integrated with our social responsibility, we stay ahead on exploring the opportunities for improving human life.***Please send all enquiries to for further information***
  • Transactions
    -
Business type
Manufacturer
Country / Region
Hong Kong S.A.R.
Main ProductsTotal employees
101 - 200 People
Total Annual Revenue
US$50 Million - US$100 Million
Year established
2000
Certifications
-
Product Certifications
-
Patents
-
Trademarks
-
Main Markets

PRODUCT CAPACITY

Factory Information

Contract Manufacturing
OEM Service Offered, Design Service Offered

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets
Total Revenue(%)
Main Product(s)
Verified
North America
9.09%
South America
9.09%
Eastern Europe
9.09%
Southeast Asia
9.09%
Africa
9.09%
Mid East
9.09%
Eastern Asia
9.09%
Western Europe
9.09%
Central America
9.09%
Northern Europe
9.09%
Southern Europe
9.09%
Verified

Trade Ability

Total Annual Revenue
US$50 Million - US$100 Million